To the full analysis
Exponent stock: growth
EXPOExponent reported $582.01M in revenue for fiscal 2025, up 4.2% on the prior year, up 7.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
6.7%
per year from 2006 to 2025, per share 8%
Earnings (Annual rate)
11.2%
per year from 2006 to 2025, per share 12.6%
Free cash flow (Annual rate)
11.2%
per year from 2006 to 2025, per share 12.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 7.8% | 6.4% | 6.7% |
| Revenue per share | 8.4% | 6.9% | 8.0% |
| Earnings | 5.1% | 9.3% | 11.2% |
| Earnings per share | 5.7% | 9.8% | 12.6% |
| Free cash flow | 4.5% | 8.3% | 11.2% |
| Free cash flow per share | 5.1% | 8.8% | 12.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $168.5M | $14.19M | $16.38M |
| 2007 | $205.15M | $20.34M | $23.27M |
| 2008 | $228.84M | $23.16M | $30.72M |
| 2009 | $227.88M | $22.13M | $24.8M |
| 2010 | $248.75M | $27.52M | $33.58M |
| 2011 | $272.45M | $32.7M | $42.76M |
| 2012 | $292.65M | $37.23M | $43.56M |
| 2013 | $296.17M | $38.64M | $55.57M |
| 2014 | $304.7M | $40.7M | $43.31M |
| 2015 | $312.83M | $43.6M | $55.11M |
| 2016 | $315.08M | $47.48M | $52.55M |
| 2017 | $347.8M | $41.31M | $63.11M |
| 2018 | $379.52M | $72.25M | $74.89M |
| 2019 | $417.2M | $82.46M | $85.02M |
| 2020 | $399.9M | $82.55M | $98.33M |
| 2021 | $466.27M | $101.2M | $117.74M |
| 2022 | $513.29M | $102.33M | $81.76M |
| 2023 | $536.77M | $100.34M | $111M |
| 2024 | $558.51M | $109M | $137.6M |
| 2025 | $582.01M | $106.01M | $122.34M |
Revenue by segment
How Exponent, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Engineering And Other Scientific85%
- Environmental And Health15%
Figures as a table
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|
| Engineering And Other Scientific | $339.8M | $319.35M | $380.91M | $427.8M | $446.89M | $469.54M | $493.89M | 84.9% |
| Environmental And Health | $77.4M | $80.55M | $85.36M | $85.5M | $89.88M | $88.97M | $88.12M | 15.1% |
| Total revenue | $417.2M | $399.9M | $466.27M | $513.29M | $536.77M | $558.51M | $582.01M | 100% |
Revenue by region
Where Exponent, Inc. generates its revenue.
- United States$520.6M89%
- Outside the US$61.4M11%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| United States | $520.59M | 89.4% |
| Outside the US | $61.42M | 10.6% |
| Total revenue | $582.01M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 2 Jan 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 2 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.